| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |